Showing results (501-510 of 618) with videos related to

Sort By:
Pageof 62
Pulmonary Circulation|May 17, 2018
Interleukin-6 trans-signaling contributes to chronic hypoxia-induced pulmonary hypertensionLevi D Maston, David T Jones, Wieslawa Giermakowska, et al.
Developmental and Comparative Immunology|December 2, 2004
IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domainsMarie-Paule Lefranc, Christelle Pommié, Quentin Kaas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2005
A vital role of tubulin-tyrosine-ligase for neuronal organizationChristian Erck, Leticia Peris, Annie Andrieux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Dialock: a new vascular access device for extracorporeal renal replacement therapy. Preliminary clinical resultsB Canaud, H My, M Morena, et al.
Parasitology Research|October 15, 2017
Prevalence, transmission, and host specificity of Cryptosporidium spp. in various animal groups from two French zoosMarwan Osman, Dima El Safadi, Sadia Benamrouz-Vanneste, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 27, 2018
Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxiaLaura Weise-Cross, Michelle A Sands, Joshua R Sheak, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Acid-Sensing Ion Channel 1a Deficiency Drives Endocrine Hypertension in Male MiceSelina M Garcia, Megan N Tuineau, Xavier A DeLeon, et al.
Elife|December 3, 2021
CRMP4-mediated fornix development involves Semaphorin-3E signaling pathwayBenoît Boulan, Charlotte Ravanello, Amandine Peyrel, et al.
Clinics and Research in Hepatology and Gastroenterology|April 14, 2021
A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-COArthur Berger, Elodie Cesbron-Métivier, Sandrine Bertrais, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancerM Ychou, J L Raoul, F Desseigne, et al.
Pageof 62